ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00480896
Recruitment Status : Completed
First Posted : May 31, 2007
Last Update Posted : September 18, 2014
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc